Citation Impact
Citing Papers
Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
2012
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
2011
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
2006
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Hepatocellular carcinoma
2003 Standout
Biology of angiogenesis in tumors of the gastrointestinal tract
2003
The Vascular Endothelial Growth Factor Receptor Kdr/Flk–1 Is A Major Regulator of Malignant Ascites Formation in the Mouse Hepatocellular Carcinoma Model
2001
Lymphangiogenesis and cancer metastasis
2002 Standout
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops
2003
Molecular pathogenesis of human hepatocellular carcinoma
2002
The tor pathway: a target for cancer therapy
2004 Standout
A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells
2006
Anti-angiogenic therapy: Rationale, challenges and clinical studies
2002
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
2001 Standout
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
2001 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Marine natural products
1990 Standout
Extracapsular Penetration is a New Prognostic Factor in Human Hepatocellular Carcinoma
2008
Human Hepatitis B Virus X Protein Is a Possible Mediator of Hypoxia-Induced Angiogenesis in Hepatocarcinogenesis
2000
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocellular carcinoma
2012 Standout
Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer
2000
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF‐C in gastric carcinoma
2001
Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significance
2003
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Inflammation and Colon Cancer
2010 Standout
Viral hepatitis and liver cancer: the case of hepatitis C
2006
Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
2004 StandoutNobel
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
1998
Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma
2004
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Tumor lymphangiogenesis and metastatic spread—New players begin to emerge
2006
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E
1998
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma
2003
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo
2006
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Advances in Malignant Mesothelioma
2005 Standout
Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma
1999
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
2000
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
1999 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Constitutive and inducible expression and regulation of vascular endothelial growth factor
2004
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
1998
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
2000
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Vegf, vegf-B, vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa
2000
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
2001
Gene Expression Patterns in Human Liver Cancers
2002
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
2000
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
The alteration of fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?
1999
Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
2000
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of S Ishigami being referenced
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
1998
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
1996
Overexpression of Matrix Metalloproteinase 9 Gene in Hepatocellular Carcinoma With Invasive Potential
1996